AEON Biopharma, Inc. Chief Accounting Officer Jennifer Sy filed a Form 4 on November 20, 2026, disclosing an open-market purchase of Class A Common Stock on November 19, 2026.

Key Highlights

  • Reporting person: Jennifer Sy, Chief Accounting Officer of AEON Biopharma, Inc.
  • Transaction: Acquisition (code P) of 153,846 shares of Class A Common Stock on November 19, 2026.
  • Weighted average price: $0.1299 per share, with individual transaction prices ranging from $0.1290 to $0.1300 per share, inclusive.
  • Resulting ownership: 1,655,022 shares of Class A Common Stock held directly following the transaction.
  • Filing signed: Alexander Wilson, as Attorney-in-Fact for Jennifer Sy, on November 20, 2026.

AEON Biopharma Chief Accounting Officer Discloses Open-Market Share Purchase

According to the Form 4 filing submitted to the SEC on November 20, 2026, Jennifer Sy, Chief Accounting Officer of AEON Biopharma, Inc. (NASDAQ:AEON), acquired 153,846 shares of the company's Class A Common Stock on November 19, 2026. The filing reports a transaction code of "P," indicating an open-market purchase. The shares were acquired at a weighted average price of $0.1299 per share.

The filing notes in a footnote that the weighted average price reflects multiple transactions executed at prices ranging from $0.1290 to $0.1300 per share, inclusive. The filing states that Sy "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."

Following the reported transaction, the filing discloses that Sy directly holds 1,655,022 shares of Class A Common Stock. No derivative securities transactions were reported in Table II of the filing. The form was signed by Alexander Wilson as Attorney-in-Fact for Jennifer Sy and was filed on November 20, 2026.

What Was Disclosed

Jennifer Sy, Chief Accounting Officer of AEON Biopharma, Inc., reported a purchase of 153,846 shares of Class A Common Stock on November 19, 2026, at a weighted average price of $0.1299, bringing her direct beneficial ownership to 1,655,022 shares.